subject area of
- Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group. Journal Articles
- BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem/progenitor cells, including CD34+38− cells, through activation of protein kinase Cβ Journal Articles
- Biting into a union of oncology and metabolism through leukemic stem cells Journal Articles
- Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era Journal Articles
- Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy Journal Articles
- Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up Journal Articles
- Cardiovascular events in chronic myeloid leukemia clinical trials. Is it time to reassess and report the events according to cardiology guidelines? Journal Articles
- Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study Journal Articles
- Choroiditis and exudative macular detachments in a post transplant leukaemic patient: an unusual presentation of Pneumocystis jiroveci infection Journal Articles
- Chromosome Abnormalities in Chronic Myeloid Leukaemia Journal Articles
- Cost-effectiveness of a Transplantation Strategy Compared to Melphalan and Prednisone in Younger Patients with Multiple Myeloma Journal Articles
- Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib Journal Articles
- Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia Journal Articles
- Electrochemical biosensor based on nanogold-modified poly-eriochrome black T film for BCR/ABL fusion gene assay by using hairpin LNA probe. Journal Articles
- Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: a systematic review protocol Journal Articles
- Exon-skipping in BCR/ABL is induced by ABL exon 2 Journal Articles
- Expression of embryonic globins by erythroid cells in juvenile chronic myelocytic leukemia Journal Articles
- Expression of p210 and p190 BCR‐ABL due to alternative splicing in chronic myelogenous leukaemia Journal Articles
-
Final report of
TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD ) study Journal Articles -
Gender and
BCR ‐ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia Journal Articles - Imatinib mesylate in children and adolescents with cancer Journal Articles
- Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a meta-analysis Journal Articles
- Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations. Journal Articles
- Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group Journal Articles
- Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Journal Articles
- Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial Journal Articles
- Outcomes of children with chronic myeloid leukemia: A population‐based cohort study Journal Articles
- Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis. Journal Articles
- Response to ‘Adverse cardiac outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors’ Journal Articles
- Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results Journal Articles
- The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia Journal Articles
- Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells Journal Articles
- Treatment Outcomes in Chronic Myeloid Leukemia: Does One Size Fit All? Journal Articles
- Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013 Conferences
- Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease Journal Articles
- Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants Journal Articles